Women who incorporated testosterone into their hormone replacement therapy regimen through bioidentical hormone pellets experienced a remarkable 35.5% reduction in the occurrence of invasive ...
Oral testosterone must be methylated as part of hormone therapy for women with reduced sexual desire, and may have negative metabolic effects compared with transdermal bioidentical testosterone.
By 2008, fewer than 5 percent of women were receiving the treatment. Within a year, the FDA had put a “black box” warning on estrogen products used in hormone therapy—the most serious ...
Until recently, most women who underwent adjuvant hormone therapy to reduce the chance of a breast cancer recurrence took tamoxifen every day for 5 years. However, with the advent of newer hormone ...